Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Abstract Background Glioblastoma (GBM) has one of the worst 5-year survival rates of all cancers. While genomic studies of the disease have been performed, alterations in the non-coding regulatory regions of GBM have largely remained unexplored. We apply whole-genome sequencing (WGS) to identify non...
Main Authors: | Sharadha Sakthikumar, Ananya Roy, Lulu Haseeb, Mats E. Pettersson, Elisabeth Sundström, Voichita D. Marinescu, Kerstin Lindblad-Toh, Karin Forsberg-Nilsson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Genome Biology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13059-020-02035-x |
Similar Items
-
Pitfalls in the diagnosis of glioblastoma
by: Bica Dorin, et al.
Published: (2023-03-01) -
Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
by: Miroslava Cuperlovic-Culf, et al.
Published: (2014-09-01) -
Immunomodulation - hope for patient with Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2018-09-01) -
Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
by: Giuseppe Stragliotto, et al.
Published: (2020-09-01) -
The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
by: Yuan Xie, et al.
Published: (2015-10-01)